Literature DB >> 10704927

Squalamine is not a proton ionophore.

B S Selinsky1, R Smith, A Frangiosi, B Vonbaur, L Pedersen.   

Abstract

Squalamine, an aminosterol antibiotic isolated from the dogfish shark, creates relatively large defects in phospholipid bilayers, allowing the unrestricted translocation of small molecules across these compromised membranes (B.S. Selinsky, Z. Zhou, K.G. Fotjik, S. R. Jones, N.R. Dollahon, A.E. Shinnar, Biochim. Biophys. Acta 1370 (1998) 218-234). However, an aminosterol structurally similar to squalamine was found to act as a proton ionophore in anionic phospholipid vesicles. In contrast with squalamine, gross membrane disruption was not observed with this synthetic analog (G. Deng, T. Dewa, S.L. Regen, J. Am. Chem. Soc. 118 (1996) 8975-8976). In this report, the ionophoric activity of squalamine was tested in anionic and zwitterionic phospholipid vesicles. No ionophoric activity was observed for squalamine in vesicles comprised of phosphatidylglycerol (PG), phosphatidylcholine (PC), or a mixture of the two lipids. Experiments using radiolabeled squalamine indicated that all of the squalamine added to PG vesicles remained with the vesicles, while approximately one-half of the squalamine added to PC vesicles was incorporated. We have synthesized the aminosterol analog of squalamine possessing ionophoric activity, and its ionophoric activity in PG vesicles was confirmed. The synthetic compound possessed no measurable lytic activity when added to preformed phospholipid vesicles. As both compounds possess significant antimicrobial activity, these results suggest that either multiple mechanisms for the antimicrobial activity of aminosterols exist, depending upon the aminosterol structure, or possibly an unrelated common mechanism for antimicrobial activity remains to be discovered.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10704927     DOI: 10.1016/s0005-2736(99)00256-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Squalamine as a broad-spectrum systemic antiviral agent with therapeutic potential.

Authors:  Michael Zasloff; A Paige Adams; Bernard Beckerman; Ann Campbell; Ziying Han; Erik Luijten; Isaura Meza; Justin Julander; Abhijit Mishra; Wei Qu; John M Taylor; Scott C Weaver; Gerard C L Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

2.  A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity.

Authors:  Michele Perni; Céline Galvagnion; Alexander Maltsev; Georg Meisl; Martin B D Müller; Pavan K Challa; Julius B Kirkegaard; Patrick Flagmeier; Samuel I A Cohen; Roberta Cascella; Serene W Chen; Ryan Limbocker; Pietro Sormanni; Gabriella T Heller; Francesco A Aprile; Nunilo Cremades; Cristina Cecchi; Fabrizio Chiti; Ellen A A Nollen; Tuomas P J Knowles; Michele Vendruscolo; Adriaan Bax; Michael Zasloff; Christopher M Dobson
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

Review 3.  Marine natural products targeting the eukaryotic cell membrane.

Authors:  Shinichi Nishimura
Journal:  J Antibiot (Tokyo)       Date:  2021-09-07       Impact factor: 2.649

Review 4.  From Marine Metabolites to the Drugs of the Future: Squalamine, Trodusquemine, Their Steroid and Triterpene Analogues.

Authors:  Oxana Kazakova; Gulnara Giniyatullina; Denis Babkov; Zdenek Wimmer
Journal:  Int J Mol Sci       Date:  2022-01-19       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.